🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this exploratory study is to evaluate the cellular and con...
Status
Terminated
Location
Regeneron Research Site
Start Date
2019-04-08
Trial ID
NCT03949673
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy of fasinumab...
Status
Terminated
Location
Regeneron Research Site
Start Date
2017-10-30
Trial ID
NCT03285646
The primary objective is to demonstrate that the auto-injector(AI) is suita...
Status
Completed
Location
Regeneron Research Facility
Start Date
2019-01-23
Trial ID
NCT03491904
Treatments Being Tested
The primary objective of this study is to evaluate the effectiveness of REG...
Status
Completed
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02447276
This is a double-blind, prospective, randomized study in which patients wil...
Status
Completed
Location
Multiple Locations
Start Date
2009-08
Trial ID
NCT00944892
The primary objective of the study is to describe the safety and tolerabili...
Status
Completed
Location
Regeneron Investigational Site
Start Date
2016-02-17
Trial ID
NCT02683239
Primary objective was to demonstrate the activity of REGN475/SAR164877 in r...
Status
Terminated
Location
Sanofi-Aventis Investigational Site Number 840024
Start Date
2009-12
Trial ID
NCT01001923
Treatments Being Tested
The primary objective of the study is to assess the safety and tolerability...
Status
Completed
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02516618
This is a randomized, double-blind, placebo-controlled, parallel-group, sin...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01053702
The primary objective of the study is to evaluate the effect of fasinumab c...
Status
Completed
Location
Regeneron Study Site
Start Date
2018-10-15
Trial ID
NCT03691974